Only about one in every six Americans who have ever been overweight or obese loses weight and maintains that loss, according to Penn State College of Medicine researchers. While that number is larger than most weight-loss clinical trials report, the majority of Americans are still unable to lose weight and keep it off…

Here’s good news for anyone trying to lose weight or has osteoporosis: Scientists from Maine are on the trail of a weight loss drug that may revolutionize how we treat these two conditions…

Why is it that some people lose weight and body fat when they exercise and eat less and others don’t? German researchers say MRI and magnetic resonance (MR) spectroscopy can provide the answer - and help predict who will benefit from lifestyle changes. Results of the study are published online and will appear in the November issue of the journal Radiology…

HealthDay - MONDAY, Aug. 23 (HealthDay News) — Close the diet books and skip
the pills. The latest weight-loss trick may be as simple as gulping a
couple of glasses of water before you eat.

HealthDay - MONDAY, Aug. 23 (HealthDay News) — Close the diet books and skip
the pills. The latest weight-loss trick may be as simple as gulping a
couple of glasses of water before you eat.

Reuters - Overweight volunteers who took Orexigen’s experimental drug Contrave, designed to reduce cravings, lost about 13 pounds (6 kg) over a year, U.S. researchers reported on Thursday.

Reuters - A compound similar to Sanofi-Aventis’ once-promising weight loss drug Acomplia helped obese mice lose weight and lower their blood fats and blood sugar without causing psychological side effects, U.S. researchers said on Monday.

Reuters - Overweight women with bladder-control problems can often improve those symptoms if they lose even a modest amount of weight, a new study suggests.

Reuters - A compound similar to Sanofi-Aventis’ once-promising weight loss drug Acomplia helped obese mice lose weight and lower their blood fats and blood sugar without causing psychological side effects, U.S. researchers said on Monday.

AP - A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug’s side effects outweigh its ability to help patients lose weight.

Next Page →